Recent advancements in transdermal patches
Literature review
Keywords:
Transdermal patches, topical delivery, sustained drug deliveryAbstract
Transdermal route of drug administration is novel as well as reliable means of sustained drug delivery. With more and more research being carried out in this field and increasing interest of researchers in this form of drug delivery, number of transdermal devices reaching the marketplace are expected to increase sharply. The aim of this review is to present latest explorations carried out in recent years utilizing possible drug candidates. Also, new polymer candidates along with novel penetration enhancers have been presented. For the purpose of study, various databases viz. Sciencedirect, Web of Knowledge, Pubmed, Google Scholar, etc. have been explored. After going through all the research work done by researchers in recent past it is appropriate to state that transdermal route is no longer reliant on few polymers and penetration enhancers but studies have now provided lot many more options for transdermal device formulation as evident from the data compilations. It can be concluded that most of the researchers have been utilizing HPMC as the preferred film forming polymer but recently use of Eudragit grades also has gained interest amongst scientists.
Downloads
References
Qin, S. Y., Zhang, A. Q., Cheng, S. X., Rong, L. & Zhang, X. Z. Drug self-delivery systems for cancer therapy. Biomaterials 234–247 (2017) doi:10.1016/j.biomaterials.2016.10.016.
Anselmo, A. C. & Mitragotri, S. An overview of clinical and commercial impact of drug delivery systems. Journal of Controlled Release vol. 190 15–28 (2014).
Sanjay, S. T. et al. Recent advances of controlled drug delivery using microfluidic platforms. Advanced Drug Delivery Reviews vol. 128 3–28 (2018).
Sharma, P. et al. Impact of solid carriers and spray drying on pre/post-compression properties, dissolution rate and bioavailability of solid self-nanoemulsifying drug delivery system loaded with simvastatin. Powder Technol. 338, 836–846 (2018).
Wu, P. C., Huang, Y. B., Chang, J. J. F., Chang, J. S. & Tsai, Y. H. Evaluation of pharmacokinetics and pharmacodynamics of captopril from transdermal hydrophilic gels in normotensive rabbits and spontaneously hypertensive rats. Int. J. Pharm. 209, 87–94 (2000).
Wilson, E. J. Three Generations : The Past , Present , and Future of Transdermal Drug Delivery Systems. Int. J. Pharm. Life Sci. (2011).
Hasan, M. K., Rahman, M. A., Shahin, S. M. & Ul Islam, M. A Comparative Evaluation Of Pioglitazone Hcl And Gliclazide -Loaded Hpmc-Pva Blend Patches. Int. J. Pharm. Sci. Res. 7, 1904–1908 (2016).
Mishra, S. K. et al. Preparation and Characterization of Transdermal Therapeutic System Containing Simvastatin: A Statistical Study. Indian J. Pharm. Educ. Res. 56, 112–120 (2022).
Shivalingam, M. R., Balasubramanian, A. & Ramalingam, K. Formulation and evaluation of transdermal patches of pantoprazole sodium. Int. J. Appl. Pharm. 13, 287–291 (2021).
Abdul Rasool, B. K., Mohammed, A. A. & Salem, Y. Y. The Optimization of a Dimenhydrinate Transdermal Patch Formulation Based on the Quantitative Analysis of In Vitro Release Data by DDSolver through Skin Penetration Studies. Sci. Pharm. 2021, Vol. 89, Page 33 89, 33 (2021).
Rajesh K, Upmanyu N & Pandey A. Anti-Emetic Potential Of Prochlorperazine Transdermal Patch In Management Of Chemotherapy Induced Nausea And Vomiting. Int. J. Pharm. Sci. Res. 12, 272–280 (2021).
Suhaitamy, M., H, B. & P.A.Z, H. Formulation and Characterization Transdermal Patches of Meloxicam. Asian J. Pharm. Res. Dev. 9, 38–42 (2021).
Joshi, R. & Garud, N. Development, optimization and characterization of flurbiprofen matrix transdermal drug delivery system using Box–Behnken statistical design. Futur. J. Pharm. Sci. 2021 71 7, 1–18 (2021).
Sahu, K., Pathan, S., Khatri, K., Upmanyu, N. & Shilpi, S. Development, characterization, in vitro and ex vivo evaluation of antiemetic transdermal patches of ondansetron hydrochloride and dexamethasone. GSC Biol. Pharm. Sci. 14, 067–078 (2021).
Yasemin A, E. A. Preparation Of Transdermal Films For Controlled Release Of Donepezil Hcl. Online J. Sci. Technol. 11, 31–36 (2021).
Malvey, S., Rao, V. & Muthu, K. Development and In Vitro Characterisation of Transdermal Therapeutic System of Ketorolac Tromethamine. Orig. Res. Artic. J Evol. Med Dent Sci 10, 93–97 (2021).
Patel, D. J., Vyas, A. M., Rathi, S. G. & Shah, S. K. Formulation and Evaluation of Transdermal Patch of Apixaban. Int. J. Pharm. Sci. Rev. Res. 69, 57–63 (2021).
Trivedi, D. & Goyal, A. Formulation and evaluation of transdermal patches containing dexketoprofen trometamol. Int. J. Pharm. Chem. Anal. 7, 87–97 (2020).
Shivalingam, M. R., Balasubramanian, A. & Ramalingam, K. Design and evaluation of medicated dermal patches of proton pump inhibitor-esomeprazole. Int. J. Pharm. Res. 12, 3038–3043 (2020).
Mamatha, J., Gadili, S. & Pallavi, K. Formulation and Evaluation of Zidovudine Transdermal Patch using Permeation Enhancers. J. Young Pharm. 12, s45–s50 (2020).
Su, Y. et al. Formulation and Pharmacokinetic Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Koumine. AAPS PharmSciTech 21, 1–11 (2020).
Samiullah, Jan, S. U., Gul, R., Jalaludin, S. & Asmathullah. Formulation and evaluation of transdermal patches of pseudoephedrine HCL. Int. J. Appl. Pharm. (2020) doi:10.22159/ijap.2020v12i3.37080.
Kulkarni, S. Formulation and Evaluation of Transdermal Patch for Atomoxetine hydrochloride. J. Drug Deliv. Ther. 9, 32–35 (2019).
Brito Raj, S., Chandrasekhar, K. B. & Reddy, K. B. Formulation, in-vitro and in-vivo pharmacokinetic evaluation of simvastatin nanostructured lipid carrier loaded transdermal drug delivery system. Futur. J. Pharm. Sci. 5, 1–14 (2019).
Mahajan, N. M. et al. Formulation development and evaluation of transdermal patch of piroxicam for treating dysmenorrhoea ARTICLE INFO. J. Appl. Pharm. Sci. 8, 35–041 (2018).
Agubata, C. O. et al. Development of Transdermal Patches for the Delivery of Chlorpheniramine in Infants using Hypromellose and Cassava Starch Composite Polymers. J. Drug Deliv. Ther. 10, 125–132 (2020).
Suksaeree, J. & Chuchote, C. Accelerated Stability Testing of a Polyherbal Transdermal Patches Using Polyvinyl Alcohol and Hydroxypropyl Methylcellulose as a Controlling Polymer Layer. J. Polym. Environ. 26, 4056–4062 (2018).
Furuishi, T. et al. Formulation design and evaluation of a transdermal drug delivery system containing a novel eptazocine salt with the Eudragit (R) E adhesive. J. Drug Deliv. Sci. Technol. 54, (2019).
Yadav, A. V. & Urade, M. N. Formulation and Evaluation of Chitosan Based Transdermal Patches of Lornoxicam for Prolonged Drug Release and to Study the Effect of Permeation Enhancer. INDIAN J. Pharm. Educ. Res. 53, 88–96 (2019).
Kharia, A., Gilhotra, R. & Singhai, A. K. Formulation And Evaluation Of Transdermal Patch For Treatment Of Inflammation. Int. J. Pharm. Sci. Res. 10, 2375–2384 (2019).
Morise, B. T. et al. Scopolamine loaded in natural rubber latex as a future transdermal patch for sialorrhea treatment. Int. J. Polym. Mater. Polym. Biomater. 68, 788–795 (2019).
Wang, Y., Zhao, X.-P. & Ruan, J.-W. Transdermal Drug Delivery System of Aceclofenac for Rheumatoid Arthritis and the Effect of Permeation Enhancers: In vitro and in vivo Characterization. Int. J. Pharmacol. 11, 456–462 (2015).
Arshad, I. et al. Effect of hydrophilic and hydrophobic polymer on the release of ketoprofen and allopurinol from bilayer matrix transdermal patch. Adv. Polym. Technol. 37, 3076–3083 (2018).
Likhitha, C., Kishore, K. & Kumar, G. V. Formulation And Invitro Evaluation Of Galantamine Patches For Transdermal Drug Delivery System. INDO Am. J. Pharm. Sci. (2018).
Harsanyova, T., Bauerova, K. & Matusova, D. Matrix adhesive system containing plant extract. Monatshefte Fur Chemie 149, 883–885 (2018).
Floriano, J. F. et al. Ketoprofen Loaded in Natural Rubber Latex Transdermal Patch for Tendinitis Treatment. J. Polym. Environ. (2018) doi:10.1007/s10924-017-1127-x.
Shehata, T. M., Mohafez, O. M. M. & Hanieh, H. N. Pharmaceutical formulation and biochemical evaluation of atorvastatin transdermal patches. Indian J. Pharm. Educ. Res. (2018) doi:10.5530/ijper.52.1.6.
Regenthal, R. et al. Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation. Drug Des. Dev. Ther. 12, 3653–3664 (2018).
Anirudhan, T. S., Nair, A. S. & Gopika, S. S. The role of biopolymer matrix films derived from carboxymethyl cellulose, sodium alginate and polyvinyl alcohol on the sustained transdermal release of diltiazem. Int. J. Biol. Macromol. 107, 779–789 (2018).
Yamsani, V. V. et al. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine. Pak. J. Pharm. Sci. 30, 2075–2083 (2017).
Malipeddi, V. R. et al. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system. Drug Deliv. Transl. Res. 7, 66–76 (2017).
Zaman, M. et al. Fabrication and Characterization of Matrix-Type Transdermal Patches Loaded with Ramipril and Repaglinide Through Cellulose-based Hydrophilic and Hydrophobic Polymers: In Vitro and Ex Vivo Permeation Studies. Polym. Plast. Technol. Eng. 56, 1713–1722 (2017).
Budhathoki, U., Gartoulla, M. K. & Shakya, S. Formulation and evaluation of transdermal patches of atenolol. Indones. J. Pharm. (2016) doi:10.14499/indonesianjpharm27iss4pp196.
Niharika, L. et al. Development and Evaluation of Transdermal Therapeutic System of Metoprolol Succinate using Acrylic Polymer. ASIAN J. Pharm. 10, 178–187 (2016).
Singh, A. & Bali, A. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride. J. Anal. Sci. Technol. 7, (2016).
Saleem, M. N. & Idris, M. Formulation Design and Development of a Unani Transdermal Patch for Antiemetic Therapy and Its Pharmaceutical Evaluation. Scientifica (Cairo). (2016) doi:10.1155/2016/7602347.
Bhattacharya, S. S. & Banerjee, S. Skin permeation of buflomedil form adhesive matrix patches. J. Adhes. Sci. Technol. (2015) doi:10.1080/01694243.2015.1009722.
Zhan, X., Mao, Z., Chen, S., Chen, S. & Wang, L. Formulation and evaluation of transdermal drug-delivery system of isosorbide dinitrate. Brazilian J. Pharm. Sci. 51, 373–382 (2015).
Mirza, F. & Lohani, A. Formulation And Characterization Of Drug In Adhesive Transdermal Patches Of Buflomedil Hydrochloride. Int. J. Pharm. Sci. Res. (2015).
Idrees, A. et al. In vitro evaluation of transdermal patches of flurbiprofen with ethyl cellulose. Acta Pol. Pharm. - Drug Res. (2014).
Solanki, S. S., Patel, K. B., Patel, J. G., Patel, M. P. & Patel, J. K. Development of matrix type transdermal patches of granisetron hydrochloride: Physicochemical and in-vitro characterization. Res. J. Pharm. Technol. 5, 973–977 (2012).
Rajabalaya, R., Xian, T. W. & David, S. R. N. Preparation and Evaluation of Transdermal Drug Delivery of Ondansetron Hydrochloride: Effect of Vegetable Oils as Permeation Enhancer. Lat. Am. J. Pharm. 31, 1005–1012 (2012).
Kshirsagar, S. J., Bhalekar, M. R. & Mohapatra, S. K. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study. DRUG Dev. Ind. Pharm. 38, 1530–1537 (2012).
Bhatia, C., Sachdeva, M. & Bajpai, M. Formulation And Evaluation Of Transdermal Patch Of Pregabalin. Int. J. Pharm. Sci. Res. 3, 569–575 (2012).
Subedi, R. K., Ryoo, J.-P., Moon, C. & Choi, H.-K. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan. Int. J. Pharm. 419, 209–214 (2011).
Rasool, B. K. A., Aziz, U. S., Sarheed, O. & Rasool, A. A. A. Design and evaluation of a bioadhesive film for transdermal delivery of propranolol hydrochloride. Acta Pharm. (2011) doi:10.2478/v10007-011-0025-3.
Amgaokar, Y. M., Chikhale, R. V, Lade, U. B., Biyani, D. M. & Umekar, M. J. Design, formulation and evaluation of transdermal drug delivery system of budesonide. Dig. J. Nanomater. Biostructures 6, 475–497 (2011).
Cho, C.-W., Jun-ShikChoi & Sang-ChulShin. Enhanced Controlled Transdermal Delivery of Torasemide Using Ethylene-vinyl Acetate. Trop. J. Pharm. Res. 10, 713–721 (2011).
Hu, Y. et al. Development of drug-in-adhesive transdermal patch for alpha-asarone and in vivo pharmacokinetics and efficacy evaluation. DRUG Deliv. 18, 84–89 (2011).
Prajapati, S. T., Patel, C. G. & Patel, C. N. Formulation and Evaluation of Transdermal Patch of Repaglinide. ISRN Pharm. (2011) doi:10.5402/2011/651909.
Latha, S., Selvamani, P., Prabu, L. S., Kumar, S. P. & Pal, T. K. Formulation and Evaluation of Matrix Diffusion Controlled Transdermal Patches of Domperidone hydrochloride. ARS Pharm. 52, 31–36 (2011).
Patel, R. P., Patel, G. & Baria, A. Formulation and evaluation of transdermal patch of Aceclofenac. Int. J. Drug Deliv. 1, 41–51 (2011).
Mamatha, T., Rao, V. J., Mukkanti, K. & Ramesh, G. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization. DARU-Journal Pharm. Sci. 18, 9–16 (2010).
Chauhan, I. & Bajpai, M. Formulation And Evaluation Of Transdermal Drug Delivery Of Raloxifene Hydrochloride. Int. J. Pharm. Sci. Res. 1, 72-U4521 (2010).
Bhatt, D. C., Dhake, A. S., Khar, R. K. & Mishra, D. N. Development and in vitro evaluation of transdermal matrix films of metoprolol tartrate. YAKUGAKU ZASSHI-JOURNAL Pharm. Soc. JAPAN 128, 1325–1331 (2008).
Mukherjee, B. et al. A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation. Eur. J. Pharm. Biopharm. 59, 475–483 (2005).
Devi, V. K., Saisivam, S., Maria, G. R. & Deepti, P. U. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. DRUG Dev. Ind. Pharm. 29, 495–503 (2003).
Patel, K. K. et al. Effect of penetration enhancers and amorphization on transdermal permeation flux of raloxifene-encapsulated solid lipid nanoparticles: an ex vivo study on human skin. Appl. Nanosci. 9, 1383–1394 (2019).
Ezealisiji, K. M. & Okorie, H. N. Size-dependent skin penetration of silver nanoparticles: effect of penetration enhancers. Appl. Nanosci. (2018) doi:10.1007/s13204-018-0886-6.
Mannam, R. & Yallamalli, I. M. Formulation optimization and study on effect of penetration enhancers on reservoir transdermal therapeutic systems of hydralazine hydrochloride. J. Young Pharm. (2017) doi:10.5530/jyp.2017.9.100.
Ameen, D. & Michniak-Kohn, B. Transdermal delivery of dimethyl fumarate for Alzheimer’s disease: Effect of penetration enhancers. Int. J. Pharm. (2017) doi:10.1016/j.ijpharm.2017.07.031.
Parhi, R. & Suresh, P. Transdermal delivery of Diltiazem HCl from matrix film: Effect of penetration enhancers and study of antihypertensive activity in rabbit model. J. Adv. Res. (2016) doi:10.1016/j.jare.2015.09.001.
Pathan, I. B. & Mallikarjuna Setty, C. Nanoemulsion system for transdermal delivery of tamoxifen citrate: Design, Characterization, effect of penetration enhancers and in vivo studies. Dig. J. Nanomater. Biostructures (2012).
Chathoth, S., Ramasami, C. & Rompicharla, N. Effect of penetration enhancers on the permeability characteristics of lisinopril transdermal delivery systems. Asian J. Pharm. 6, 130–136 (2012).
Zafar, S., Ali, A., Aqil, M. & Ahad, A. Transdermal drug delivery of labetalol hydrochloride: Feasibility and effect of penetration enhancers. J. Pharm. Bioallied Sci. 2, 321 (2010).
Gabiga, H., Cal, K. & Janicki, S. X. Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system. Int. J. Pharm. 199, 1–6 (2000).
Jafri, I., Shoaib, M. H., Yousuf, R. I. & Ali, F. R. Effect of permeation enhancers on in vitro release and transdermal delivery of lamotrigine from Eudragit®RS100 polymer matrix-type drug in adhesive patches. Prog. Biomater. 8, 91–100 (2019).
Shabbir, M. et al. Influence of different formulation variables on the performance of transdermal drug delivery system containing tizanidine hydrochloride: In vitro and ex vivo evaluations. Brazilian J. Pharm. Sci. 54, 1–12 (2018).
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.








